Response to letter regarding article, “High-Density Lipoprotein Cholesterol, Size, Particle Number, and Residual Vascular Risk After Potent Statin Therapy.”

Benzer Materyaller

• HDL cholesterol, size, particle number, and residual vascular risk after potent statin therapy
  Yazar:: Mora, Samia, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• On-Treatment Non-HDL Cholesterol, Apolipoprotein B, Triglycerides, and Lipid Ratios in Relation to Residual Vascular Risk after Treatment with Potent Statin Therapy: The JUPITER Trial
  Yazar:: Mora, Samia, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low‐Density Lipoprotein Cholesterol
  Yazar:: Lawler, Patrick R., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Association of Air Pollution Exposures with High Density Lipoprotein Cholesterol and Particle Number: The Multi-Ethnic Study of Atherosclerosis
  Yazar:: Bell, Griffith, ve diğerleri
  Baskı/Yayın Bilgisi: (2017)
• Cholesterol Efflux Capacity, HDL Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin)
  Yazar:: Khera, Amit V., ve diğerleri
  Baskı/Yayın Bilgisi: (2017)